# Heparin Induced Thrombocytopenia: Pharmacoeconomics

> **NCT00456001** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 200 (actual)

## Conditions studied

- Heparin Induced Thrombocytopenia (HIT)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00456001
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-09
- **Final completion:** 2009-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2009-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456001, "Heparin Induced Thrombocytopenia: Pharmacoeconomics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00456001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*